InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

ORDINARY FULLY PAID (ASX: OPT) - Announcements

DELISTED - Current share price for OPT : $0.013

ASX company news and announcements for ORDINARY FULLY PAID (OPT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ORDINARY FULLY PAID (OPT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ORDINARY FULLY PAID (OPT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ORDINARY FULLY PAID (OPT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Opthea Provides Corporate Update 19 Aug 2025 8:39AM $0.600 $0.013 fallen by 97.83%
$18 Application for quotation of securities - OPT 8 Aug 2025 6:03PM $0.600 $0.013 fallen by 97.83%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2025 8:29AM $0.600 $0.013 fallen by 97.83%
$18 Long Term Suspended Entities 16 Jul 2025 4:15PM $0.600 $0.013 fallen by 97.83%
$18 Details of Company Address 4 Jul 2025 1:18PM $0.600 $0.013 fallen by 97.83%
$18 Final Director's Interest Notice Quinton Oswald 2 Jun 2025 9:14AM $0.600 $0.013 fallen by 97.83%
$18 Final Director's Interest Notice Dr Susan Orr 2 Jun 2025 9:13AM $0.600 $0.013 fallen by 97.83%
$18 Final Director's Interest Notice Dr Julia Haller 2 Jun 2025 9:13AM $0.600 $0.013 fallen by 97.83%
$18 Final Director's Interest Notice Anshul Thakral 2 Jun 2025 9:13AM $0.600 $0.013 fallen by 97.83%
$18 Opthea Provides Corporate Update 2 Jun 2025 8:44AM $0.600 $0.013 fallen by 97.83%
$18 Ceasing to be a substantial holder 12 May 2025 8:10AM $0.600 $0.013 fallen by 97.83%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 8:53AM $0.600 $0.013 fallen by 97.83%
$18 Opthea Provides Corporate Update 10 Apr 2025 9:21AM $0.600 $0.013 fallen by 97.83%
$18 Continuation of Suspension from Quotation 31 Mar 2025 12:44PM $0.600 $0.013 fallen by 97.83%
$18 Opthea Announces Decision to Discontinue Wet AMD Trials 31 Mar 2025 12:41PM $0.600 $0.013 fallen by 97.83%
$18 Becoming a substantial holder 31 Mar 2025 8:17AM $0.600 $0.013 fallen by 97.83%
$18 Ceasing to be a substantial holder 25 Mar 2025 8:18AM $0.600 $0.013 fallen by 97.83%
$18 Opthea Announces COAST Phase 3 Trial Topline Results 24 Mar 2025 10:41AM $0.600 $0.013 fallen by 97.83%
$18 Voluntary suspension 19 Mar 2025 9:36AM $0.600 $0.013 fallen by 97.83%
$18 Trading Halt 17 Mar 2025 8:41AM $0.600 $0.013 fallen by 97.83%
$18 Becoming a substantial holder 14 Mar 2025 7:28PM $0.600 $0.013 fallen by 97.83%
$18 Application for quotation of securities - OPT 14 Mar 2025 4:13PM $0.600 $0.013 fallen by 97.83%
$18 Application for quotation of securities - OPT 14 Mar 2025 4:10PM $0.600 $0.013 fallen by 97.83%
$18 Update - Application for quotation of securities - OPT 14 Mar 2025 1:22PM $0.603 $0.013 fallen by 97.84%
$18 Application for quotation of securities - OPT 11 Mar 2025 1:18PM $0.643 $0.013 fallen by 97.98%

51 - 75 of 733 results

Page 3 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.